J-STAGE Home  >  Publications - Top  > Bibliographic Information

Chemical and Pharmaceutical Bulletin
Vol. 52 (2004) No. 4 P 498-499

Language:

http://doi.org/10.1248/cpb.52.498

Communications to the Editor

Thalidomide has been found to exhibit weak nitric oxide synthase (NOS)-inhibitory activity. Structural development studies of thalidomide showed that some N-2,6-dimethylphenylhomophthalimide analogs possess NOS-inhibiting activity.

Copyright © 2004 The Pharmaceutical Society of Japan

Article Tools

Share this Article